'Hematological malignancies' diaporamas de présentation

Autoimmunity III

Autoimmunity III. Therapeutics of Autoimmune Diseases. General Ag-specific Gene therapy IVIg Plasmapheresis BMT. Specific SLE RA MS. Autoimmune Therapeutics. Antigen-specific Therapy. Induce tolerance Determined by Form and purity of Ag Dose Route of administration

663 views • 47 slides

Blood Disorder (Hematologic Disease)

Blood Disorder (Hematologic Disease). Presented by : Jackie Peter D11A012 Khirrol Nizam D11A014 Lee Joy Yoong D11A015. Types of Hematologic Disease. Anaemias (presented by Josephin and Herlina ) Hemoglobinopathies (congenital abnormality of Hb or Hb synthesis)

468 views • 37 slides

Hematological Malignancies Disease Market: Pin-Point Analysis For Changing Competitive Dynamics 2018-2025

47 views • 4 slides

Hematologic Malignancies Market Price and Gross Margin, Specification, Dynamics Forecast 2025

Hematologic Malignancies Market is predicted to reach USD 85.8 billion by 2025 depending on the growing prevalence of hematologic malignancies across the globe. Hematologic malignancies are also known as blood cancers that are found in bone marrow, blood and lymph nodes

46 views • 4 slides